NO933465L - Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling - Google Patents

Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling

Info

Publication number
NO933465L
NO933465L NO933465A NO933465A NO933465L NO 933465 L NO933465 L NO 933465L NO 933465 A NO933465 A NO 933465A NO 933465 A NO933465 A NO 933465A NO 933465 L NO933465 L NO 933465L
Authority
NO
Norway
Prior art keywords
indazol
tetrahydro
derivatives
preparation
new
Prior art date
Application number
NO933465A
Other languages
English (en)
Norwegian (no)
Other versions
NO933465D0 (no
Inventor
Wolfgang Eberlein
Wolfgang Engel
Gerhard Mihm
Klaus Rudolf
Gunther Engelhardt
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO933465D0 publication Critical patent/NO933465D0/no
Publication of NO933465L publication Critical patent/NO933465L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Toys (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO933465A 1992-09-29 1993-09-28 Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling NO933465L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4232544A DE4232544A1 (de) 1992-09-29 1992-09-29 Arzneimittel enthaltend 1,5,6,7-Tetrahydro-4H-indazol-4-one, neue 1,5,6,7-Tetrahydro-4H-indazol-4-one und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
NO933465D0 NO933465D0 (no) 1993-09-28
NO933465L true NO933465L (no) 1994-03-30

Family

ID=6469076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933465A NO933465L (no) 1992-09-29 1993-09-28 Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling

Country Status (20)

Country Link
US (1) US5468766A (cs)
EP (1) EP0590558B1 (cs)
JP (1) JPH06211802A (cs)
KR (1) KR940006588A (cs)
CN (1) CN1088434A (cs)
AT (1) ATE131053T1 (cs)
AU (1) AU667237B2 (cs)
BG (1) BG98125A (cs)
CA (1) CA2107026A1 (cs)
CZ (1) CZ203193A3 (cs)
DE (2) DE4232544A1 (cs)
EE (1) EE9400233A (cs)
FI (1) FI934252L (cs)
HU (1) HUT67452A (cs)
IL (1) IL107142A0 (cs)
NO (1) NO933465L (cs)
NZ (1) NZ248773A (cs)
PL (1) PL300522A1 (cs)
SK (1) SK94593A3 (cs)
ZA (1) ZA937179B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795584B2 (en) 2013-07-30 2017-10-24 University Of South Florida Treating an atypical protein kinase C enzyme abnormality

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3691180A (en) * 1970-07-31 1972-09-12 Ciba Geigy Corp Cycloalkano (c)pyrazoles
KR880009024A (ko) * 1987-01-27 1988-09-13 게리 디.스트리트 기관지 확장제용 디피라졸
DE4024862A1 (de) * 1990-08-04 1992-02-13 Hoechst Ag 4,5,6,7-tetrahydro-3-aryl-indazole, verfahren zu ihrer herstellung und ihre verwendung als herbizide
US5108485A (en) * 1990-08-31 1992-04-28 American Cyanamid Company Herbicidal 2-(2-imidazolin-2-yl)-benzazoles

Also Published As

Publication number Publication date
EE9400233A (et) 1996-02-15
ATE131053T1 (de) 1995-12-15
BG98125A (en) 1994-06-30
CA2107026A1 (en) 1994-03-30
JPH06211802A (ja) 1994-08-02
CN1088434A (zh) 1994-06-29
KR940006588A (ko) 1994-04-25
HUT67452A (en) 1995-04-28
IL107142A0 (en) 1993-12-28
EP0590558B1 (de) 1995-12-06
DE59301096D1 (de) 1996-01-18
AU667237B2 (en) 1996-03-14
PL300522A1 (en) 1994-04-05
FI934252A0 (fi) 1993-09-28
NZ248773A (en) 1995-07-26
HU9302750D0 (en) 1993-12-28
AU4863993A (en) 1994-04-14
FI934252A7 (fi) 1994-03-30
FI934252L (fi) 1994-03-30
DE4232544A1 (de) 1994-03-31
ZA937179B (en) 1995-06-28
US5468766A (en) 1995-11-21
SK94593A3 (en) 1994-09-07
NO933465D0 (no) 1993-09-28
EP0590558A1 (de) 1994-04-06
CZ203193A3 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
CA2107105A1 (en) Heterocyclic-cyclic amine derivatives
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
MY106280A (en) Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use.
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
NO996108L (no) 9-oksinerytromycinderivater
PL289487A1 (en) Method of producing new aminophenol derivatives
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
NO971625L (no) Nye peptider med immunomodulatoriske effekter
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
NO913612D0 (no) Fremgangsmaate for fremstilling av nye skualen-syntetase-inhibitorer.
FI921641A7 (fi) Menetelmä lääkeaineina käyttökelpoisten 1-(pyrido/3,4-b/-1,4-oksatsin-4-yyli)-1H-indolien valmistamiseksi
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO305554B1 (no) Nye bis-naftalimider og farmas°ytisk blanding for behandling av kreft
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO922114L (no) Kjemiske forbindelser
NO982863L (no) Nye forbindelser med analgetisk effekt
NO933465L (no) Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling
FI854512A0 (fi) Ny kristallform av benzotiazin-dioxidsaltet.
AU2067592A (en) New n-(isoquinolin-5-ylsulphonyl)azacycloalkanes, process for the preparation thereof, and pharmaceutical compositions containing them
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
HU913482D0 (en) Process for the production of new piperazino-alkyl-benzoxazine- and tiazine derivatives, carrying heterocyclic substituent, and of medical preparations containing such compounds
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
GEP19991792B (en) Substituted Propane-2-ol Derivatives, Process for Their Preparation, Pharmaceutical Composition and Process for Its Preparation